<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Gugler, Philippe</dc:creator>
  <dc:creator>Keller, Michael</dc:creator>
  <dc:creator>Tinguely, Xavier</dc:creator>
  <dc:date>2015</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Purpose – This paper aims to focus on the role of clusters as home and host country- specific advantages for multinational enterprises (“MNEs”) in the organization of their  internal and external networks to optimize the diffusion and generation of new  knowledge. Strategic asset-seeking investment has been a major driver of the  internalization of innovation activities performed by MNEs abroad. This paper  demonstrates the attractiveness of foreign clusters in the global innovation process of  MNEs. The main assumption is that location within innovative clusters may foster the  ability of firms to generate new innovations. Design/methodology/approach – This  paper illustrates the theoretical developments through the example of firms located in  the Basel pharmaceutical clusters which have invested in other clusters abroad.  Findings – The results are based on an in-depth patent data analysis and confirm the  importance of clusters in an innovation-driven industry. Originality/value – This paper  focuses on the role of clusters as home and host country-specific advantages for  “MNEs” in the organization of their internal and external networks to optimize the  diffusion and generation of new knowledge. Strategic asset-seeking investment has  been a major driver of the internalization of innovation activities performed by MNEs  abroad. This paper demonstrates the attractiveness of foreign clusters in the global  innovation process of MNEs. The main assumption is that location within innovative  clusters may foster the ability of firms to generate new innovations. This paper  illustrates the theoretical developments through the example of firms located in the  Basel pharmaceutical clusters which have invested in other clusters abroad. The  results are based on an in-depth patent data analysis and confirm the importance of  clusters in an innovation-driven industry.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/309525</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/309525/files/2015_Gugler_Role.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1108/CR-09-2014-0033</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Competitiveness Review. - Emerald Group Publishing Limited. - 2015, vol. 25, no. 3, p. 324-340</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Clusters</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Innovation</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Pharmaceutical industry</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/33</dc:subject>
  <dc:title xmlns:ns4="xml" ns4:lang="en">The Role of Clusters in the Global Innovation Strategy of MNEs : Theoretical Foundations and Evidence from the Basel Pharmaceutical Cluster</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
